Cannabis Compound Database: Browsing Compounds

Displaying compounds 6001 - 6025 of 6258 in total

Cannabis ID CAS Number	Name	Structure	Formula Monoisotopic Mass	Physiological Effect	Compound Status
CDB006150 57-50-1	Sucrose		C₁₂H₂₂O₁₁ 342.1162	Antioxidant	Expected but not Quantified
CDB006151 609343-71-7	Stearic acid		C₁₈H₃₆O₂ 284.2715	Schizophrenia	Expected but not Quantified
CDB006152 14982-50-4	Pectin		C₆H₁₀O₇ 194.0427	Not Available	Expected but not Quantified
CDB006153 67701-02-4	Palmitic acid		C₁₆H₃₂O₂ 256.2402	Schizophrenia	Expected but not Quantified
CDB006154 462-94-2	Cadaverine		C₅H₁₄N₂ 102.1157	Kidney disease Cancer Thyroid cancer	Expected but not Quantified
CDB006155 57-87-4	Ergosterol		C₂₈H₄₄O 396.3392	Eye irritant Skin irritant Hormone	Expected but not Quantified
CDB006156 8043-29-6	Glycerol		C₃H₈O₃ 92.0473	Schizophrenia	Expected but not Quantified
CDB006157 112-44-7	Undecanal		C₁₁H₂₂O 170.1671	Perfuming agent Insect attractant	Expected but not Quantified
CDB006158 41579-20-8	Fructose		C₆H₁₂O₆ 180.0634	Obesogen	Expected but not Quantified
CDB006159 77-92-9	Citric acid		C₆H₈O₇ 192.027	Schizophrenia Hyperoxalemia Cancer Lung cancer Flavoring agent Antimicrobial agent	Detected and Quantified
CDB006160 149-32-6	Erythritol		C₄H₁₀O₄ 122.0579	Uremia	Expected but not Quantified
CDB006161 15194-15-7	Ammonia		H₃N 17.0265	Eye irritant Skin irritant Epilepsy Homocitrullinuria Aciduria Hepatobiliary disorders Nervous system disorders Lethargy Seizure General disorders and administration site conditions Pain Cough Psychiatric disorders Irritability Gastrointestinal disorders Vomiting Metabolism and nutrition disorders Neurotoxin Toxin	Expected but not Quantified
CDB006162 124-40-3	Dimethylamine		C₂H₇N 45.0578	Weight loss Kidney disease Coma Psychosis Uremia Nervous system disorders Seizure Renal and urinary disorders Chronic kidney disease Psychiatric disorders Confusion Agitation Cardiac disorders Cardiovascular disease Gastrointestinal disorders Vomiting Nausea Uremic toxin	Expected but not Quantified
CDB006163 608-66-2	Galactitol		C₆H₁₄O₆ 182.079	Neurotoxin Hepatotoxin Toxin	Expected but not Quantified
CDB006164 6000-40-4	Glyceric acid		C₃H₆O₄ 106.0266	Schizophrenia D-glyceric acidemia	Detected and Quantified
CDB006165 69-79-4	Maltose		C₁₂H₂₂O₁₁ 342.1162	Not Available	Expected but not Quantified
CDB006166 112-80-1	Oleic acid		C₁₈H₃₄O₂ 282.2559	Schizophrenia	Expected but not Quantified
CDB006167 16891-48-8	Pyroglutamic acid		C₅H₇NO₃ 129.0426	Schizophrenia Nervous system disorders Tremor Seizure Metabolism and nutrition disorders	Expected but not Quantified
CDB006168 51-67-2	Tyramine		C₈H₁₁NO 137.0841	Coma Hypotension Hypertension Metabolism and nutrition disorders Hypoglycemia Musculoskeletal and connective tissue disorders Muscle cramp Muscle weakness General disorders and administration site conditions Nervous system disorders Tremor Headache Gastrointestinal disorders Vomiting Nausea Psychiatric disorders Depression Anxiety Neurotransmitter	Detected and Quantified
CDB006169 87-99-0	Ribitol		C₁₀H₁₈ 138.1409	Antimicrobial agent Antibacterial	Expected but not Quantified
CDB006170 526-95-4	Gluconic acid		C₆H₁₂O₇ 196.0583	Schizophrenia Antimicrobial agent Antimalarial	Expected but not Quantified
CDB006171 25525-21-7	Glucaric acid		C₆H₁₀O₈ 210.0376	Not Available	Expected but not Quantified
CDB006172 2197-37-7	Linoleic acid		C₁₈H₃₂O₂ 280.2402	Schizophrenia Hypertension Cancer Thyroid cancer Anti-inflammatory Antidiabetic Antineoplastic agent Anticancer agent	Expected but not Quantified
CDB006173 636-61-3	Malic acid		C₄H₆O₅ 134.0215	Not Available	Detected and Quantified
CDB006174 544-63-8	Myristic acid		C₁₄H₂₈O₂ 228.2089	Schizophrenia	Expected but not Quantified

Displaying compounds 6001 - 6025 of 6258 in total